The report highlights that insulin-derived amyloidosis can mimic other injection-site reactions and should be considered when ...

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...

Participants regained their original weight within an average of 1.7 years after stopping any type of weight loss medication.

In peer-reviewed study on mice, Technion scientists say novel method using harmless microneedle patches 'opens the door' to treat war wounds, diabetes, and inflammatory skin diseases ...

You’ve probably seen the commercials on TV, or maybe you’ve seen the drastic before-and-after pictures on social media: ...

Recent estimates suggest that roughly 60 per cent of cats and dogs in the US are obese. Read more at straitstimes.com. Read ...

Drug major Zydus Lifesciences Limited has received a key regulatory clearance from the Subject Expert Committee (SEC) ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...

Discover how advanced detectors are driving improvements in biopharma quality assurance by enhancing precision across ...

Oclaiz is a subcutaneous long-acting octreotid depot, designed for optimized disease control and convenient self-administration. The product is based on Camurus' FluidCrystal technology and is ...

GLP-1 drugs like Ozempic and Mounjaro have significant health benefits for type 1 diabetes, including weight loss, despite ...